PATENT CLAIM ANALYSIS

Application Number: 16317341
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-06
Patent Classification: ["514", "338000"]

Abstract:
Derivatives of 1,2,4-Triazolo-[3,4-b]-1,3,4-thiadiazoles according to formula (I), as set forth below: processes for production thereof, pharmaceutical compositions containing the same and the use thereof in treatment of cancer.

Claim (Index 2):
The compound according to  claim 1 , wherein R 1  and R 2  are the same or different and are selected from the group consisting of: C 1 -C 3  alkyl, phenyl, methyphenyl,

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.11765
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12187524', '14403014', '13628216', '14927502', '11894900']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7753604783633974
- 35 USC 102 Novelty (BERT): 0.5057124691423054
- Combined Prediction Score: 0.7483956774412882
- Mean Citation Score: 245.702024
- Max Citation Score: 248.3725
- Similarity Product: 178.24865406036378

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test